J Drugs Dermatol. 2024 Mar 1;23(3):SF395747s6-SF395747s11. doi: 10.36849/jdd.SF395747.
Atopic Dermatitis (AD) epidemiologic studies report a higher incidence and prevalence among populations with skin of color (SOC). Additionally, differences in AD underlying gene mutations and skin morphology are observed to lead to frequent and prominent xerosis, pruritus, and pigmentary sequelae in patients of color. However, populations with SOC are underrepresented in dermatology clinical trials, including AD. This article reviews the nuances in AD epidemiology, clinical presentation, and impact on quality-of-life among populations with SOC, plus highlight the role of skincare in AD management. J Drugs Dermatol. 2024;23:3(Suppl 2):s6-11.
特应性皮炎（AD）的流行病学研究报告显示，皮肤色素较深（SOC）人群的发病率和患病率更高。此外，AD 潜在基因突变和皮肤形态的差异导致有色人种患者经常出现明显的干燥、瘙痒和色素后遗症。然而，SOC 人群在皮肤科临床试验中代表性不足，包括 AD 临床试验。本文综述了 SOC 人群中 AD 的流行病学、临床表现和对生活质量的影响，并强调了皮肤护理在 AD 管理中的作用。J 皮肤病药物杂志。2024;23:3（增刊 2）：s6-11。
